Monday, 25 Sep 2017

You are here

Breastfeeding Rates Lower in Lupus

It is a common practice for rheumatologists to discuss medication-related teratogenicity and disease implications in case of pregnancy.  Yet, discussion of breastfeeding are often omitted.

Besides being after the fact and little known about the safety of breastfeeding, there are few studies of breastfeeding in lupus and most of these are small in size and have other limitations.  This is in stark contrast with the abundance of published studies on lupus and pregnancy.

Breastfeeding is widely promoted in general population for the benefit of both mother and newborn.  But how safe is breastfeeding in SLE patients?  Do we have reasonable, consistent and accurate recommendations to give our lupus patients?

A cross-sectional study done by Acevedo et al involved a group of physicians from Argentina and compared 36 pregnancies (in 31 SLE patients) with the same number of non-SLE controls to retrospectively assess breastfeeding in lupus.

The number of patients not initiating breastfeeding was higher (19%) in lupus compared to non-lupus mothers (5.6%) who opted not to nurse (p value = 0.07).  For those who breastfed, the average duration of breast feeding was 12 months in no-SLE patient as opposed to 6 months in SLE group (p 0.003).

Interestingly, when it came to reasons for weaning, half of the non-SLE mothers thought they breastfed their children for appropriate amount of time (53%), but SLE patients most often weaned bcause of starting lupus-related medications (41%). Lack of breast milk supply was the second most common cause in both groups (24% and 28% respectively).

Analysis of the medications in SLE group showed that majority of the patient who stopped nursing were on low dose corticosteroids or hydroxychloroquine. The authors did not provide any additional data on type or exact dose of steroids and no additional data on other DMARDs.

The study concluded that breastfeeding duration could potentially be optimized by improved patient education in SLE women intending to become pregnant. 

 

Disclosures: 
The author has no conflicts of interest to disclose related to this subject

Add new comment

More Like This

Isolated SS-B Not Associated with Connective Tissue Disease

A one-year prospective study of 624 patients undergoing autoantibody testing for anti-SS-A and/or anti-SS-B autoantibodies finds that isolated anti-SS-B autoantibodies was not associated with features or the diagnosis of any specific connective tissue diseases (CTD).

Half of Takayasu's Arteritis Relapse

A French retrospective study of 318 Takayasu's arteritis (TA) patients shows that 50% of patients will relapse and experience a vascular complication ≤10 years from diagnosis. 

Past Infection, Lung Disease Raise Risk for Myopathy

Infections and noninfectious pulmonary disease were associated with an increased risk for idiopathic inflammatory myopathies (IIM), a Swedish study found.

Idiopathic Inflammatory Myopathy Quadruples Death Risk

A Swedish population-based study found a nearly fourfold greater risk of all-cause mortality in idiopathic inflammatory myopathy (IIM) patients compared with the general population.

Risk peaked to almost 10% in the first year, pointing to the need for careful monitoring of newly diagnosed patients, reported Marie Holmquist, MD, PhD, of the Karolinska Institute in Stockholm, and colleagues in Annals of the Rheumatic Diseases.

Duration of Azathioprine Maintenance in AAV Does Not Alter Relapse Rates

A European multicentre study examined whether the duration of azathioprine (AZA) maintenance therapy in ANCA-associated vasculitis patients would influence the relapse rate during long-term follow-up.